Pharmaceutical Quality Assurance

EUROPEAN

CURRICULUM VITAE

FORMAT SCIENTIFIC CURRICULUM VITAE

PERSONAL INFORMATION

DR. PIPERAKI, Stavroula-Ina

Name

**, ****** ********** ***., **- 15127, MELISSIA, ATHENS, GREECE

Address in Athens

10, AVENUE ALPHAND, 75116, PARIS, FRANCE

Address in Paris

+30-694*-******, +30-210-*******, +33(0)965297780 FRANCE,

965297780

Telephone GSM

E-mail ***********@******.***

***********@******.***, ***********@******.**,

Nationality Hellenic

SUMMARY / PROFILE

• Pharmacist, PhD Degree, and a great experience in research,

and

pharmaceutical industry, business and computer sciences.

• I am working for many years on academic research and I have a great

teaching experience at University level. The outcome of this work is a

series of 19 publications in international journals as well as 23

series

participations

participations in international symposia and many lectures.

• I am working as an International Business Consultant (see “work

usiness

experience” section).

experience

• I am successfully involved in the worldwide development of new

pharmaceutical compounds and the pre- and post-marketing surveillance

of new pharmaceutical entities, as well as Pricing and Reimbursement

of

strategies

strategies, in a multinational pharmaceutical company (Sanofi S.A.)

directing the Regulatory Affairs and Pharmacovigilance Departments.

• I established my one company, a private business. Further, I have created

a computer assisted Pharmaceutical Care Centered. This work gave me

the

the opportunity to have a direct interaction with the public and to handle,

on a first-degree, health care issues related to drug safety, efficacy, as well

degree,

as

as drug monitoring and Pharmacovigilance reporting.

• BEPA (Bureau of European Policy Advisers) of the European Commission:

BEPA

Representative of a NPO within the BEPA (active participation on meetings,

making presentations, lobbing and presidency of think-tank European group).

• In my career I have been always characterized by excellent interpersonal

In

skills

skills coupled with a proactive and entrepreneurial approach and thus, I

can communicate to the public and build good working relationships.

Based on my experience, I am capable of providing leadership for

timetabling, strategic objectives, budget building and analysis,

coordinating activities carried out through group; further, working with

good

good project management flair, I can ensure that developmental timetables

and objectives can be met.

• I have excellent knowledge of French and English, as well as good

knowledge of Portuguese and elementary of Italian.

• Excellent knowledge of Computer Programming, Social Networking, as

Exc rogramming,

well as excellent knowledge of MS Office (word, excel, powerpoint, etc.)

well

• Honors: awards & distinctions, listed in international biographical

Honors: listed

dictionaries,

dictionaries, university & national school awards for “Excellency”.

school

CORE COMPETENCIES

Business & pharmaceutical industry, pharmaceutical science & research,

harmaceutical

pharmaceutical

pharmaceutical development, regulatory affairs, pharmacovigilance, personalized

medicine

medicine, pharmaceutical care, sales, computer programming, foreign languages.

Page 1 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

r. P

WORK EXPERIENCE

Pharmaceutical Sciences - Private Sector

Type of business or sector

INTERNATIONAL CONSULTANT @ OWNER OF A PRIVATE BUSINESS

July 1997 – now

• International Consultant: Business Consultancy Strategic Planning

Research & Development Regulatory Affairs & Pharmacovigilance Market

Research & Feasibility Studies Crisis Management Lobbying Social

Networks Management Quality and Knowledge Management Business Process

Re-engineering Cluster Management Innovation & Creativity.

• Creation & Management of a private business

• Establishment of A PHARMACEUTICAL CARE CENTER supported by a Computer

Assisted Program of Pharmaceutical Care and Pharmacovigilance Reporting.

& Type of business or sector Private Sector

2009 - now BEPA (Bureau of European Policy Advisers) of the European Commission:

Representative of a NPO within the BEPA.

& Type of business or sector Pharmaceutical Sciences

July 1997 – now SCIENTIFIC ASSOCIATE IN THE UNIVERSITY OF ATHENS, in the topics of

Pharmaceutical Chemistry, Personalized Medicine & Pharmaceutical Care,

May 1993 -June 1998 DIRECTOR REGULATORY AFFAIRS & PHARMACOVIGILANCE, R&D DEPARTMENTS

Sanofi S.A.

Type of business or sector Pharmaceutical Industry

• Directing the teams of the two departments and successfully accomplishing

the following responsibilities related to my job profile:

• Representing the Affiliate in the Corporate R&D Department, participating in

the European and the International Decision Development Team concerning the

company’s new products portfolio;

• Quality Assurance Manager & “Pharmacien Responsable”, for the local

production plant;

• Representing the company within the European Medicines Agency, related to

procedures of drug marketing authorization licenses as well as Pricing and

Reimbursement strategies;

• Working in collaboration with the EME for the approval to conduct Clinical

Trials in hospitals as well as pre-and post-marketing Pharmacovigilance

procedures and reports (EudraVigilance);

• Representing the company within the National Organization for Medicines;

• Representing the affiliate within the “United Cities & Local Governments

Organisms”, concerning environmental safety issues related to chemical

entities and residues;

• Representing the company in the National Organism of Industrial and

Intellectual Properties and within the Corporate International Trademarks

Department ;

• Directing the Regulatory Affairs & Pharmacovigilance activities in other

countries in Europe.

January 1997- December 1994 1. TEACHING ON THE POSTGRADUATE PROGRAM OF “PHARMACEUTICAL

ANALYSIS” Division of the Pharmaceutical Chemistry, University of Athens.

Pharmaceutical Sciences

Type of business or sector

General subject: “Advanced Courses on Pharmaceutical Analysis”, covering

the following topics:

• “Chiral Chromatography in drug analysis: Theory”

• “Chiral Chromatography in drug analysis”(Laboratory lesson)

• “Capillary Electrophoresis: theory and principles”

• “Capillary Electrophoresis: applications in the separation of chiral drugs”

2. TEACHING ON THE POSTGRADUATE PROGRAM OF “PHARMACEUTICAL

TECHNOLOGY”, Division of the Pharmaceutical Technology, University of Athens.

Pharmaceutical Sciences

Type of business or sector

General subject: “Modern techniques in pharmaceutical analysis”.

Page 2 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

WORK EXPERIENCE

January 1994–August 1994 COLLABORATION WITH THE UNIVERSITY OF YORK

Pharmaceutical Sciences

Type of business or sector

Invited by the Professor Dr. David Goodall (University of York – Department of

Chemistry) to visit his research group and initiate a collaboration study, in both

Liquid Chromatography and Capillary Electrophoresis in order to produce a

unified theory on chiral separations.

The result of this successful and innovative project was a joint research paper,

presented to the 3rd International Symposium on Capillary Electrophoresis, and a

scientific publication in the Journal of Chromatography.

This research program was sponsored by the British Council of Athens after

the submission and the approval of a relevant project.

September 1991–April 1993 TWO YEAR RESEARCH PROGRAM

Pharmaceutical Sciences

Type of business or sector

Participation in a two-year research program supported by the National Drug

Organization for the subsidy of a doctoral thesis.

January 1991 – June 1992 SCIENTIFIC TRAINING MANAGER – PART TIME JOB, Pancosmetic Hellas Ldt

Pharmaceutical Industry

Type of business or sector

Organisational structuring of a Training Department: Setting up a scientific

library; Creation of relevant bibliography and its monitoring; Setting up two

series of lectures for the Training of Executives on scientific topics in the field

of Cosmetology (see Lectures ‘section).

January 1990–September 1993 POSTGRADUATE SCHOLAR

Pharmaceutical Sciences

Type of business or sector

Division of Pharmaceutical Chemistry, Laboratory of Pharmaceutical Analysis.

Teaching in the “Laboratory Lessons of Pharmaceutical Analysis”.

SCIENTIFIC PUBLICATIONS

Scientific Research – Pharmaceutical Sciences

Type of sector

Scientific Research – Pharmaceutical

1. S. Piperaki, Pharmaceutiki, 25, 2013 (accepted for publication).

Sciences

“Academic Education and Life Long Learning: Horizon 2020 & the evolution

of the pharmaceutical profession in Europe”.

2. S. Piperaki, Pharmaceutiki, 24, 2012.

“The Age of Personalized Medicine : pharmacogenomics, the development

of a targeted therapy”.

3. S. Piperaki, PHARMACY Management & Communication, 11, July 2011.

‘’Pharmaceutical Care Services in a post-crisis business environment’’.

4. Branimir Bertoša, Biserka Kojić-Prodić, Rebecca C. Wade,, Michael Ramek,

Stavroula Piperaki, Anna Tsantili-Kakoulidou, and Sanja Tomić, J. Chem. Inf.

Comput. Sci., 43(5), 1532-1541, July 2003. “A new approach to predict the

biological activity of molecules based on similarity of their interaction fields

and the logP and logD values: application to auxins”.

5. A.Tzantili-Kakoulidou, I. Panteri, S. Piperaki, F. Csizmadia and F. Darvas,

European J. Drug Metab. & Pharmacokinetics, 24(3), 205-212, 2000.

“Prediction of distribution coefficients from structure comparison of

calculated and experimental data for various drugs”.

6. V. Lambroussi, S. Piperaki, A. Tzantili-Kakoulidou, J. of Planar Chromatogr.,

12, 124-128, 1999.

“Formation of inclusion complexes between cyclodextrins as mobile phase

additives in RPTLC, and Fluoxetine, Norfluoxetine and Promethazine”.

7. A.Tzantili-Kakoulidou, S. Piperaki, I. Panteri, F. Csizmadia and F. Darvas,

Quant. Struct. – Act. Relat., 16, 315-316, 1997.

“Prediction of distribution coefficient from structure. The influence of ion

pair formation as reflected in experimental and calculated values”.

Page 3 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

SCIENTIFIC PUBLICATIONS

Scientific Research – Pharmaceutical Sciences

Type of sector

8. S. Piperaki and M. Parissi-Poulou, J. Liq. Chromatogr. Relt. Techno.,19(9), 1405-

Scientific Research – Pharmaceutical

Sciences 1421, 1996. “Evaluation of the chromatographic behavior of Fluoxetine and

Norfluoxetine by using different cyclodextrins as mobile phase additives in

HPLC and fluorimetric detection”.

9. S. Piperaki and M. Parissi-Poulou, J. Chromatogr., 729, 19-28, 1996.

“Enantiomeric separation of zopiclone, its metabolites and products of

degradation using a β-cyclodextrin bonded phase”.

10. M. Parissi-Poulou and S. Piperaki, Pharmakeutiki, 9, 30-41,

1996. “Analytical methods for the separation of chiral compounds”.

11. S. Piperaki, European Society of Regulatory Affairs: Rapporteur, 2(1), 1995.

“Clinical trials procedure in Greece”.

12. S. Piperaki, A. Tzantili-Kakoulidou and M. Parissi-Poulou, Chirality, 7,

257-266, 1995. “Solvent Selectivity in Chiral Chromatography using a ß-CD

bonded phase”.

13. S. Piperaki, S.G. Penn and D.M. Goodall, J. Chromatogr., 700, 59-67,1995.

“A systematic approach to treatment of enantiomeric separations in capillary

electrophoresis and liquid chromatography. II. A study of the enantiomeric

separation of fluoxetine and norfluoxetine”.

14. S. Piperaki, Eur. J. of Drug Metabol. & Pharmacokinetics, 19, Supp. No 2, 58,

1994. “Chiral HPLC: a new analytical approach in enantiomeric separations”.

15. S. Piperaki, Eur. J. of Drug Metabol. & Pharmacokinetics, 19, Supp. No 2, 17,

1994. “The future European Regulatory System and the International

Harmonisation Conference”.

16. S. Piperaki, M. Parissi-Poulou, Chirality, 5, 258-266, 1993.

“The use of CDs as chiral selectors for the direct resolution of the

enantiomers of fluoxetine and its metabolite norfluoxetine by HPLC”.

17. S. Piperaki, S. Perakis, M. Parissi-Poulou, J. Chromatogr., 660, 339-350, 1994.

“Liquid chromatographic retention behaviour and separation of

Promethazine and Isopromethazine on a β-cyclodextrin phase column”.

18. S. Piperaki, M. Parissi-Poulou and M. Koupparis, J. Liq. Chromatogr., 16(16),

3487-3508, 1993.

“A separation study of tricyclic antidepressant drugs by HPLC using a

β-cyclodextrin bonded stationary phase”.

19. S. Piperaki, M. Parissi-Poulou, Pharmakeutiki, 5, 2-19, 1992.

“Chiral Separations in Pharmaceutical Analysis by HPLC”.

20. S. Piperaki, M. Parissi-Poulou, Pharmakeutiki, 3, 150-163, 1990.

“Application of Cyclodextrins in High Performance Liquid Chromatography”.

ANNOUNCEMENTS

INTERNATIONAL CONGRESSES

Scientific Research – Pharmaceutical Sciences

Type of sector

1. 16th Pharmaceutical Symposium, June 2013, Athens, Greece.

S. Piperaki, as invited speaker, “Academic Education and Life Long

Learning: Horizon 2020 & the evolution of the pharmaceutical

profession in Europe”.

2. 3rd Pharmacists Meeting on Business and Communication

S.Piperaki. ‘’Pharmaceutical Care Services in a post-crisis business

environment’’, 22 January 2012, Athens, Greece, as invited speaker.

3. 14th Pharmaceutical Symposium, May 2009, Athens, Greece.

S. Piperaki: “Personalized Medicine and Patient-centered Care.”

4. 13th Pharmaceutical Symposium, May 2007, Athens, Greece.

S. Piperaki and A.Tsantili-Kakoulidou: “Patient-centered Pharmacy : a new

model of pharmaceutical practice based on a pharmaceutical care program.”

5. 11th Pharmaceutical Symposium, May 2003, Athens, Greece.

S. Piperaki, as invited speaker, Round Table “Pharmaceutical Care”.

Page 4 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

ANNOUNCEMENTS

INTERNATIONAL CONGRESSES

Scientific Research – Pharmaceutical Sciences

type of sector

6. 8th Pharmaceutical Symposium,October 1996, Athens, Greece.

K. Pistos, S. Piperaki and M. Parissi-Poulou:

“Determination of EDTA in paracetamol injectable solution (“Apotel

7. 8th Pharmaceutical Symposium, October 1996, Athens, Greece.

V. Lambroussi, S. Piperaki and A. Tsantili-Kakoulidou:

“Study of the association of a series of racemic mixtures with cyclodextrins

using TLC”.

8. QSAR Symposium, September 1996, Lausanne, Switzerland.

A.Tsantili-Kakoulidou, S. Piperaki, I. Panteri, F. Csizmadia and F. Darvas:

“Prediction of distribution coefficient from structure. The influence of ion

pair formation as reflected in experimental and calculated values”.

9. Euroanalysis IX, September 1-7, 1996, Bologna, Italy.

S. Piperaki and M. Parissi-Poulou:

“Determination of the enantiomers of zopiclone and its metabolites in

biological fluids using a ß-cyclodextrin bonded phase”(as invited speaker).

10. 6th European Congress of Biopharmaceutics and Pharmacokinetics,

April 22- 24, 1996, Athens, Greece.

A.Tsantili-Kakoulidou, I. Panteri, S. Piperaki, F. Csizmadia and F. Darvas.

“Method for the prediction of distribution coefficients from structure

comparison between calculated and experimental data for various drugs”.

11. 19th International Symposium on Column Liquid Chromatography,

May 28-June 2, 1995, Innsbruck, Austria.

S. Piperaki and M. Parissi-Poulou:

“Enantiomeric separation of zopiclone, its metabolites and products of

degradation using a ß-cyclodextrin bonded phase”.

12. 5th International Symposium on Chiral Discrimination, September 25-28,

1994, Stockholm, Sweden. S. Piperaki and M. Parissi-Poulou:

"Solvent Selectivity in Chiral Chromatography using a ß-cyclodextrin

bonded phase".

13. 3rd International Symposium on Capillary Electrophoresis, August 24-26,

1994, York, U.K.. S. Piperaki, S.G. Penn and D.M. Goodall

"A systematic approach to treatment of enantiomeric separations in

Capillary electrophoresis and liquid chromatography. II. Influence of

Cyclodextrins selector type and mobile phase composition with the

enantiomers of fluoxetine and norfluoxetine".

14. 7th Pharmaceutical Symposium,June 11-13 1994, Athens, Greece

S. Piperaki, and M. Parissi-Poulou: "Chemical structure factors affecting

chiral recognition and separation on ß-cyclodextrin bonded phase: a study

of eight different racemic mixtures".

15. 7th Pharmaceutical Symposium,June 11-13 1994, Athens, Greece

S. Piperaki, "Capillary Electrophoresis: theory, principles and applications in

the separation of drugs’ enantiomers".

16. First International Meeting on Scientific Basis of Modern Pharmacy, June

8-11, 1994, Athens, Greece.

S. Piperaki, (as invited speaker), “The Future European Regulatory System

and the International Harmonisation Conference".

17. First International Meeting on Scientific Basis of Modern Pharmacy, June

8-11, 1994, Athens, Greece.

S. Piperaki and M. Parissi-Poulou:

"Chiral HPLC: a new analytical approach in enantiomeric separations".

18. 20th International Symposium on Chromatography, June 19-24, 1994,

Bournemouth, UK. S. Piperaki and M. Parissi-Poulou: "Simultaneous

determination of hyoscine butylbromide and acetaminophen In

pharmaceutical formulation using a ß-cyclodextrin bonded-phase column".

Page 5 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

ANNOUNCEMENTS

INTERNATIONAL CONGRESSES

Scientific Research – Pharmaceutical Sciences

Type of sector

19. Euroanalysis VIII, September 5-11, 1993, Edinburgh, UK.

S. Piperaki and M. Parissi-Poulou:

"Effectiveness of different CDs media to enhance fluorescence

chromatographic detection of Fluoxetine and Norfluoxetine".

20. HPLC’93, 17th International Symposium on Column Liquid

Chromatography, May 9-14, 1993 Hamburg, Germany.

S. Piperaki, M. Parissi-Poulou: "Liquid chromatographic retention behavior

and separation of Promethazine and Isopromethazine on a β-cyclodextrin

phase column".

21.HPLC’93, 17thInternational Symposium on Column Liquid Chromatography

May 9-14, 1993, Hamburg, Ger many.

S. Piperaki, A. Axarlis, M. Parissi-Poulou:

"Determination of Haloperidol by HPLC using fluorescence derivatization

with dansylhydrazine".

22. 3rd International Symposium on Chiral Discrimination, October 5 - 8, 1992

Tübingen, Germany.

S. Piperaki and M. Parissi-Poulou:

"The use of CDs as chiral selectors for the direct resolution of the enantiomers

of fluoxetine and its metabolite norfluoxetine by HPLC".

23. 5th Pharmaceutical Congress, May 1990.

S. Piperaki, M. Parissi - Poulou and M. Koupparis:

"Applications of cyclodextrins in pharmaceutical analysis using liquid

chromatography of high performance".

1. President of the Organisation Committee of the International Conference

ORGANISATION OF

‘’Construire l’Europe, Construire le Monde’’, Athens, June 2008.

CONGRESSES

2. President of the Organisation Committee of the Euro-Mediterranean

Conference “Identification Des Différences Culturelles Qui Empêchent

La Création D’un Espace Communautaire En Méditerranée”, Athens,

February 2006.

OTHER RESEARCH ACTIVITIES

SCIENTIFIC COLLABORATION, with the Division of Toxicology, Medical School

• June –September 1991

of the University of Athens. Development of new analytical methods

determining Albendazole and Mebendazole in biological fluids and in

secluded echinococcus saccules, for patients who have been subjected to

special therapeutic treatment and have, thereafter, been treated by surgical

operation.

KEY LECTURES

« Harmonisation and Solidarity within the EU”, as invited speaker,

1-2 February 2013

•

Colloquium “Plus Europe”, Barcelona Chamber of Commerce, Barcelona.

«Gouvernance et Solidarités Européennes », as invited speaker, Conférence

23 January 2013

•

Publique « La dimension Européenne de la Citoyenneté », Paris, France.

«Les politiques en faveur d’une solidarité intergénérationnelle : différentes

26 September 2012

•

perspectives en Europe – La Génération « sandwich »», Commission

Européenne – BEPA, AS PRESIDENT of a European Think-Thank Group.

7 February 2012 « LES DROITS SOCIAUX EN CRISE ? « LA GRECE A L’EPREUVE »,

•

1e Rencontres Régionales Européennes, IRTS Ile-de-France,

Fondation ITSRS ; as invited speaker.

12 July 2011 « L'EUROPE ET SA JEUNESSE: LES POLITIQUES DE JEUNESSE DE LA COMMISSION

•

EUROPEENNE », Commission Européenne – BEPA, AS RAPPORTEUR of a

European Think-Thank Group .

Page 6 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

KEY LECTURES

« OUVERTURE DES ETATS GENERAUX DE LA LAÏCITE EN EUROPE : LA GRECE” ; as

22 January 2011

•

invited speaker.

Colloque de l’Observatoire International de la Laïcité, la Société des Gens de

Lettres - Hôtel de Massa, Paris, France. ‘’LAÏCITE ET SANTE : UN ETAT DES

LIEUX” ; as invited speaker.

Colloque de l’Observatoire International de la Laïcité, Assemblée Nationale de

27 Mars 2010

•

France, Paris.

6TH PANHELLENIC SYMPOSIUM “GALINOS”, as invited speaker, “The role of the

16.04.2005

•

pharmacist in the 21st century” Subject: “Pharmaceutical Care”.

• 22.04.1994 UNIVERSITY OF YORK, DEPARTMENT OF CHEMISTRY, as invited speaker

Subject: “The use of Cyclodextrins in Inclusion Chromatography: applications

in Pharmaceutical Analysis”.

• 11.03.1994 SECOND ANNUAL WORLDWIDE REGULATORY AFFAIRS MEETING,

Sanofi-Aventis S.A., as invited speaker

Subject: “Second International Conference on Harmonisation (ICH2): Quality”.

ERASMUS EDUCATIONAL PROGRAM – DIVISION OF PHARMACEUTICAL

• 21.01.1994

TECHNOLOGY, LABORATORY OF BIOPHARMACEUTICS AND PHARMACOKINETICS

as invited speaker by the Professor Panagiotis Macharas

Subject: “Chiral Chromatography: theory, principles and applications in drug

analysis”.

• November 1991 - July 1992 A SERIES OF 16 LECTURES*, PANCOSMETIC HELLAS LTD

General topic of Pharmaceutical Cosmetology

• January - July 1991 14 LECTURES*, PANCOSMETIC HELLAS LTD

A SERIES OF

General topic of Pharmaceutical Cosmetology,

*list of specific subjects available on request.

BOOKS PUBLISHED

• « Un chemin quotidien en quête de vérité », Ina Piperaki & Jean – Michel

Reynaud, Editions Bruno le Prince, Paris, octobre 2011.

• « L’effacement de dettes : une solution à la crise mondiale », Ina Piperaki &

Jean -Michel Reynaud, Editions Bruno le Prince, Paris juin 2011.

• « Dictionnaire de la laïcité », co-auteur, Editions Armand Collin, Paris, mai 2011.

PARTICIPATION IN

INTERNATIONAL CONGRESSES

“Bioavailability and Bioequivalence: Focus on Physiological Factors and

•

Variability”, organized by EUFEPS & the COST Working Group I of

Action B25, October 1-2, 2007, Athens, Greece.

“Counterfeits: Financial and Social Consequences, Legal confrontation”,

•

organized by the American-Hellenic Chamber of Commerce, December 12,

1995, Athens, Greece.

"Recent advances and applications of capillary electrophoresis", European

•

Meeting, April 20, 1994, Zeneca Specialties, Blackley-Manchester, U.K.

European Federation of Industrial Pharmaceutical Associations - INFO '93

•

(Organized with the Commission of the European Communities): "Status

in the Regulatory Area: Regulatory Harmonization - practical reality in

Europe versus the international quest", December 15-16, 1993, Brussels,

13th European Society of Regulatory Affairs Meeting : "Regulatory

•

Streamlining of Drug Development", October 5-6, 1993, Geneva,

Switzerland

2nd International Symposium on Chiral Discrimination, May 27-31, 1991,

•

Rome, Italy.

5th International Symposium on Cyclodextrins, March 28-30, 1990, Paris,

•

France.

3rd Symposium on Mass Spectrometry, December 7-8, 1989,Athens, Greece

•

Page 7 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

EDUCATION AND TRAINING

SUPPORT OF DOCTORAL THESIS: “The use of Cyclodextrins in High Performance

• 28/6/1993

Liquid Chromatography (HPLC): Applications in the Pharmaceutical Analysis”.

Department of Pharmacy, University of Athens.

• Name and type of organisation

The presentation took place in front of a five-Professor’s Committee,

Michalis Koupparis, Professor

George Foskolos, Professor

Maria Parissi-Poulou, Associate Professor

Anna Tsantili – Kakoulidou, Associate Professor

Aikaterini Byza, Associate Professor

which judged unanimously the prototype of the thesis and decided to award

it with the grade : “Excellent”.

Doctor in Pharmacy, PhD.

• Title of qualification awarded

• from November 1989 ELABORATION OF DOCTORAL THESIS

to September 1993

Division of Pharmaceutical Chemistry, Department of Pharmacy, University of

• Name and type of organisation

Athens.

providing education and training

• Principal subjects Elaboration of doctoral thesis comprising research activity, both in the context

of the inquired topic and in the broader field of Analytical Chemistry applied

to Pharmaceutical Analysis.

Collaboration with the Department of Biology (in the field of molecular biology

and more precisely in computer modeling studies) and the Department of

Chemistry (Laboratory of Analytical Chemistry) of the University of Athens.

Master in Pharmacy

• Title of qualification awarded

• 1984 - 1989 STUDIES IN PHARMACEUTICAL SCIENCES

• Name and type of organisation Department of Pharmacy, School of Health Sciences, University of Athens

providing education and training

Graduation Grade “Excellent”, 1st in graduation rank).

• Level in national classification

Admission after national examination 1984 - ranked 2nd at the entry

• Level in national classification

performance.

Computer Programming & Analysis

• Title of qualification awarded

• 1983 - 1985 TWO-YEAR COURSE ‘’ANALYSIS and COMPUTER PROGRAMMING’’

Hellenic Center of Productivity

• Name and type of organisation

General Subject: “Program of Education of Enterprises’ and

providing education and training

Organisations’ Executives” (12 hours weekly)

Graduation grade “Excellent” (96/100, 1st in graduation rank).

• Level in national classification

French Language Teaching Licence

• Title of qualification awarded

ACQUISITION, after examination, of the OFFICIAL LICENCE OF TEACHING FRENCH

• 1984

AS A FOREIGN LANGUAGE

National Council of Education (Α.Π. Δ5/1562, 15/5/84).

• Name and type of organisation

• 1971 - 1983 BASIC EDUCATION

• Name and type of organisation Greek-French School of “Ursulines” & Arsakios Elementary School

providing education and training

Graduation from the Greek-French School of “Ursulines” – Grade “Excellent”

• Level in national classification

(19.4/20). National School Awards in 1983, 1982, 1981, 1980, 1979.

Page 8 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

TRAINING SEMINARS &

WORKSHOPS

• “Biological therapy of chronic diseases. Combination of Homotoxicology and

Homoeopathy. Auto–Sansuis–Therapy Neurotherapy.” The Interna-tional

Society of Homotoxicology, 28-29 May, 1999, Athens, Greece

• “Chirality”, 18 December 1995, Division of Pharmaceutical Chemistry,

University of Athens, Greece.

• “Capillary Electrophoresis”, 5th International Symposium on

Pharmaceutical and Biomedical Analysis, 24 September 1994, Stockholm,

Sweden.

• “Principles and Practice of Chiral Separations”, 20th International

Symposium on Chromatography, 19 June 1994, Bournemouth, UK.

• “Developments in Biopharmaceutics-Pharmacokinetics”, 30 May 1992,

University of Athens, Greece.

• 5th International Symposium on Cyclodextrins, March 28-30, 1990, Paris,

France Postgraduate Seminar “Pharmaceutical analysis in Biological

Liquids”, 4-30 May, 1992. (University of Athens).

• “Advanced Euro-HPLC Training Course and Workshop”, 7-10 April 1992,

Patras, Greece (COMETT).

PERSONAL SKILLS

AND COMPETENCES

MOTHER TONGUE GREEK

OTHER LANGUAGES FRENCH

• Reading skills EXCELLENT

• Writing skills EXCELLENT

• Verbal skills EXCELLENT

ENGLISH

• Reading skills EXCELLENT

• Writing skills EXCELLENT

• Verbal skills EXCELLENT

PORTUGUESE (LEARNING)

• Reading skills GOOD

• Writing skills GOOD

• Verbal skills BASIC

ITALIAN

• Reading skills ELEMENTARY

• Writing skills ELEMENTARY

• Verbal skills ELEMENTARY

AWARDS & NOMINATIONS

DICTIONARY OF INTERNATIONAL BIOGRAPHY, Inclusion in the “Dictionary of

•

International Biography, 36th Edition”, International Biographical Centre

Cambridge, England, December 2011.

Selection for inclusion in the 15th, respective editions of WORLD WHO’S WHO

•

OF WOMEN, of the year 2010.

DICTIONARY OF INTERNATIONAL BIOGRAPHY, Inclusion in the “Dictionary of

•

International Biography, 35th Edition”, International Biographical Centre

Cambridge, England, December 2009.

2000 OUTSTANDING INTELLECTUALS OF THE 21ST CENTURY AWARDS, Inclusion

•

in the “Dictionary of International Biography, 34th Edition”, International

Biographical Centre Cambridge, England, November 2008.

WOMAN OF THE YEAR 2006 MEDAL, American Biographical Institute, Inc. 2007

•

500 GREATEST GENIUSES OF THE 21ST CENTURY, Published by the American

•

Biographical Institute, Inc., 15 March 2005, in “Pharmacy, Computer Science &

Philosophy”.

Selection for inclusion in the 27th, 26th, 24th, 23rd, 22nd, 21st, 20th, 19th, 13th,

•

respective editions of Marquis WHO’S WHO IN THE WORLD, of the years 2010,

2009, 2007, 2006, 2005, 2004, 2003, 2002, 1996.

Page 9 - Curriculum vitae of Dr. PIPERAKI, Stavroula-Ina

MEMBERSHIPS

Elected Member of the Hellenic-Brazilian Chamber, responsible for

•

Foreigner Affairs (2012-2015).

• In the American Association for the Advancement of Science (since

1994-).

• In The New York Academy of Sciences (since 2008-).

• In the European Society of Regulatory Affairs (since 1994).

• In the Pan-Hellenic Association of Pharmacists (since 1997-).

• In the Pharmaceutical Association of Pharmacists of Attica(since 1997-).

• In Amicale, Worldwide Society of the "Ursulines" School Graduates

(since 1984-).

• Observatoire International de la Laïcité contre les dérives

communautaires (since 2009-).

TECHNICAL SKILLS

AND COMPETENCES

EXCELLENT KNOWLEDGE OF PROGRAMMING AND USE OF THE

Contact this candidate